Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change  »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$522.02

26.69 (5.39%)

, NVS

Novartis

$86.02

3.46 (4.19%)

10:33
06/22/17
06/22
10:33
06/22/17
10:33
Recommendations
Regeneron, Novartis analyst commentary at Raymond James »

Regeneron price target…

REGN

Regeneron

$522.02

26.69 (5.39%)

NVS

Novartis

$86.02

3.46 (4.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

ORCL

Oracle

, HAIN

Hain Celestial

$33.16

0.13 (0.39%)

09:19
06/22/17
06/22
09:19
06/22/17
09:19
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS: Oracle…

ORCL

Oracle

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

AAL

American Airlines

$48.43

0.4 (0.83%)

NVS

Novartis

ESNC

EnSync

ACN

Accenture

STM

STMicroelectronics

TMHC

Taylor Morrison

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

  • 07

    Jul

  • 12

    Jul

  • 29

    Aug

  • 22

    Jun

  • 22

    Jun

REGN

Regeneron

$522.02

26.69 (5.39%)

, NVS

Novartis

$82.56

0.96 (1.18%)

09:03
06/22/17
06/22
09:03
06/22/17
09:03
Hot Stocks
Regeneron details royalty agreement with Novartis for canakinumab »

Regeneron (REGN) provided…

REGN

Regeneron

$522.02

26.69 (5.39%)

NVS

Novartis

$82.56

0.96 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

MRK

Merck

$65.46

0.93 (1.44%)

, PINC

Premier

$35.00

0.07 (0.20%)

08:49
06/22/17
06/22
08:49
06/22/17
08:49
Hot Stocks
Premier, Merck expand collaboration to address chronic care, vaccination rates »

Merck (MRK) and Premier…

MRK

Merck

$65.46

0.93 (1.44%)

PINC

Premier

$35.00

0.07 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

REGN

Regeneron

$522.02

26.69 (5.39%)

, CELG

Celgene

$132.83

6.61 (5.24%)

08:16
06/22/17
06/22
08:16
06/22/17
08:16
Recommendations
Regeneron, Celgene, Vertex, Alexion, AbbVie, Amgen, Gilead, Biogen analyst commentary at Leerink »

Leerink sees reasons for…

REGN

Regeneron

$522.02

26.69 (5.39%)

CELG

Celgene

$132.83

6.61 (5.24%)

VRTX

Vertex

$134.83

8.5 (6.73%)

ALXN

Alexion

$123.58

4.53 (3.81%)

ABBV

AbbVie

$71.34

0.12 (0.17%)

AMGN

Amgen

$171.35

5.06 (3.04%)

GILD

Gilead

$67.50

1.91 (2.91%)

BIIB

Biogen

$278.60

12.6 (4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 06

    Jul

  • 13

    Jul

  • 19

    Jul

  • 25

    Jul

  • 14

    Aug

  • 23

    Oct

  • 03

    Feb

NVS

Novartis

$82.56

0.96 (1.18%)

08:14
06/22/17
06/22
08:14
06/22/17
08:14
Technical Analysis
Technical View: Novartis at new 52-week high »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

LLY

Eli Lilly

$82.64

-0.11 (-0.13%)

07:55
06/22/17
06/22
07:55
06/22/17
07:55
Conference/Events
FDA Pediatric Oncology Subcommittee of Oncologic Drugs Committee holds a meeting »

The Pediatric Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

TWTR

Twitter

$17.78

0.87 (5.14%)

, CHK

Chesapeake

$4.52

-0.39 (-7.94%)

07:35
06/22/17
06/22
07:35
06/22/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

TWTR

Twitter

$17.78

0.87 (5.14%)

CHK

Chesapeake

$4.52

-0.39 (-7.94%)

NKE

Nike

$52.59

1.03 (2.00%)

ORCL

Oracle

$46.33

0.49 (1.07%)

PFE

Pfizer

$33.88

0.32 (0.95%)

HAL

Halliburton

$42.23

-1.17 (-2.70%)

MAT

Mattel

$19.99

-0.03 (-0.15%)

WPX

WPX Energy

$8.71

-0.56 (-6.04%)

FMSA

Fairmount Santrol

$3.48

-0.27 (-7.20%)

OTIC

Otonomy

$17.50

1.45 (9.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 11

    Jul

  • 19

    Jul

  • 24

    Jul

  • 02

    Aug

  • 27

    Aug

DRRX

Durect

$1.45

0.01 (0.69%)

, NVS

Novartis

$82.56

0.96 (1.18%)

07:09
06/22/17
06/22
07:09
06/22/17
07:09
Hot Stocks
Durect completes enrollment in Phase 3 trial for pain relief candidate Posimir »

Durect (DRRX) has…

DRRX

Durect

$1.45

0.01 (0.69%)

NVS

Novartis

$82.56

0.96 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.